HONG KONG –With a new deal with Ferring Holdings Ltd. to option its innovative microbiome-focused technology, Israel's Mybiotics Pharma Ltd. is looking to expand its market and develop new products. Its second option agreement with Ferring is based on validation of Mybiotics' microbiome-based therapeutic technology focused on women's health.